2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 130.84 | NA | 122.23 | 121.68 | 121.32 | NA | 110.91 | 108.64 | 108.29 | NA | 92.69 | NA | NA | |
Earnings Per Share Basic | -0.62 | -0.67 | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 | -0.71 | -0.57 | -0.62 | -0.66 | NA | NA | |
Earnings Per Share Diluted | -0.62 | -0.67 | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 | -0.71 | -0.57 | -0.62 | -0.66 | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 10.01 | -0.00 | 25.20 | 0.12 | 0.23 | 0.25 | 0.34 | 0.36 | 0.42 | 0.57 | 0.67 | 0.84 | 0.95 | |
Revenues | 10.01 | -0.00 | 25.20 | 0.12 | 0.23 | 0.25 | 0.34 | 0.36 | 0.42 | 27.83 | 0.67 | 0.84 | 0.95 | |
Operating Expenses | 100.37 | 92.19 | 98.78 | 106.17 | 101.40 | 73.10 | 86.24 | 78.18 | 63.14 | 68.29 | 61.66 | 194.42 | 43.36 | |
Research And Development Expense Excluding Acquired In Process Cost | 82.40 | 77.50 | 81.49 | 88.20 | 82.83 | 67.28 | 66.90 | 60.51 | 51.67 | 51.91 | 44.97 | 45.15 | 30.62 | |
General And Administrative Expense | 19.80 | 16.77 | 18.48 | 20.12 | 19.58 | 16.37 | 16.07 | 17.46 | 16.07 | 15.55 | 14.68 | 14.42 | 12.73 | |
Operating Income Loss | -90.36 | -92.20 | -73.58 | -106.05 | -101.18 | -72.85 | -85.89 | -77.81 | -62.72 | -67.72 | -60.99 | -193.58 | -42.41 | |
Allocated Share Based Compensation Expense | 27.19 | 19.27 | 21.84 | 23.41 | 21.52 | 13.82 | 13.72 | 15.15 | 13.46 | 10.22 | 12.42 | 16.15 | 9.67 | |
Other Comprehensive Income Loss Net Of Tax | -0.96 | 3.19 | 2.69 | -0.28 | 4.62 | 2.97 | -1.48 | -2.69 | -8.13 | -1.10 | 0.07 | -0.08 | -0.05 | |
Net Income Loss | -81.39 | -83.50 | -65.73 | -98.50 | -94.24 | -67.50 | -84.17 | -76.79 | -62.05 | -67.46 | -60.83 | -193.40 | -42.18 | |
Comprehensive Income Net Of Tax | -82.35 | -80.31 | -63.04 | -98.78 | -89.62 | -64.53 | -85.66 | -79.48 | -70.18 | -68.55 | -60.76 | -193.47 | -42.24 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 841.44 | 843.98 | 906.96 | 962.02 | 1037.56 | 1099.77 | 1168.72 | 889.42 | 949.88 | 1008.44 | 671.62 | 714.40 | 771.35 | |
Liabilities | 95.68 | 91.98 | 128.59 | 151.90 | 154.15 | 149.55 | 168.95 | 109.78 | 107.91 | 110.64 | 100.53 | 95.87 | 38.56 | |
Liabilities And Stockholders Equity | 841.44 | 843.98 | 906.96 | 962.02 | 1037.56 | 1099.77 | 1168.72 | 889.42 | 949.88 | 1008.44 | 671.62 | 714.40 | 771.35 | |
Stockholders Equity | 745.76 | 752.00 | 778.37 | 810.12 | 883.41 | 950.22 | 999.77 | 779.64 | 841.97 | 897.81 | 571.09 | 618.53 | 732.79 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 770.10 | 770.10 | 831.80 | 884.35 | 958.39 | 1019.50 | 1087.30 | 855.79 | 915.79 | 976.24 | 639.26 | 681.28 | 742.43 | |
Cash And Cash Equivalents At Carrying Value | 152.87 | 143.74 | 151.33 | 145.90 | 161.28 | 151.79 | 354.64 | 107.74 | 119.44 | 280.12 | 228.56 | 260.07 | 262.72 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 155.57 | 146.44 | 154.03 | 148.61 | 163.85 | 154.37 | 357.22 | 110.31 | 122.02 | 282.70 | 231.14 | 262.65 | 263.60 | |
Other Assets Current | 7.30 | 3.31 | 3.68 | 3.39 | 4.08 | 3.26 | 11.58 | NA | NA | 1.76 | NA | NA | NA | |
Available For Sale Securities Debt Securities | 596.74 | 606.35 | 659.29 | 725.67 | 776.53 | 847.12 | 699.15 | 730.25 | 778.73 | 677.95 | 387.95 | 411.15 | 463.36 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | NA | 34.48 | NA | NA | NA | 30.02 | NA | NA | NA | 20.91 | NA | NA | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | 23.58 | NA | NA | NA | 18.39 | NA | NA | NA | 14.37 | NA | NA | NA | |
Property Plant And Equipment Net | 9.88 | 10.90 | 10.70 | 11.75 | 11.95 | 11.63 | 11.39 | 8.92 | 8.90 | 6.54 | 6.24 | 6.56 | 5.91 | |
Available For Sale Debt Securities Amortized Cost Basis | 597.90 | 606.55 | 662.67 | 731.75 | 782.33 | 857.54 | 712.54 | 742.16 | 787.95 | 679.04 | 387.94 | 411.21 | 463.34 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 37.14 | 30.27 | 50.75 | 71.58 | 70.47 | 63.71 | 71.43 | 43.90 | 41.69 | 24.32 | 28.52 | 25.39 | 16.08 | |
Accounts Payable Current | 7.97 | 9.21 | 13.35 | 14.78 | 11.83 | 10.58 | 9.48 | 4.30 | 8.05 | 8.28 | 6.32 | 7.87 | 5.59 | |
Accrued Liabilities Current | 22.36 | 14.89 | 31.49 | 26.91 | 28.05 | 22.70 | 29.36 | 22.11 | 15.22 | 13.95 | 20.10 | 15.40 | 8.87 | |
Other Liabilities Current | 1.66 | 1.20 | 1.10 | 25.26 | 26.15 | 26.15 | 26.90 | 15.41 | 16.33 | 0.40 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Lease Liability Noncurrent | 47.16 | 48.50 | 49.81 | 51.10 | 52.31 | 53.47 | 54.60 | 20.02 | 20.55 | 21.06 | 21.55 | 22.02 | 22.48 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 745.76 | 752.00 | 778.37 | 810.12 | 883.41 | 950.22 | 999.77 | 779.64 | 841.97 | 897.81 | 571.09 | 618.53 | 732.79 | |
Common Stock Value | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | NA | NA | NA | |
Additional Paid In Capital | 2228.76 | 2152.65 | 2098.72 | 2067.43 | 2041.94 | 2019.13 | 2004.14 | 1698.37 | 1681.22 | 1666.89 | 1271.63 | 1258.31 | 1179.10 | |
Retained Earnings Accumulated Deficit | -1481.97 | -1400.58 | -1317.09 | -1251.35 | -1152.85 | -1058.61 | -991.11 | -906.93 | -830.15 | -768.10 | -700.64 | -639.81 | -446.41 | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -1.16 | -0.20 | -3.39 | -6.08 | -5.80 | -10.42 | -13.39 | -11.91 | -9.22 | -1.09 | 0.01 | -0.06 | 0.01 | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 27.19 | NA | 21.84 | 23.41 | 21.52 | NA | 13.72 | 15.15 | 13.46 | NA | 12.42 | 16.15 | 9.67 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -50.32 | -89.19 | -75.40 | -68.60 | -67.13 | -57.08 | -66.14 | -57.09 | -49.17 | -39.71 | -53.20 | -28.14 | 46.64 | |
Net Cash Provided By Used In Investing Activities | 10.53 | 59.68 | 71.36 | 51.28 | 75.31 | -146.94 | 27.19 | 43.39 | -112.38 | -292.75 | 20.79 | 26.07 | -233.62 | |
Net Cash Provided By Used In Financing Activities | 48.92 | 21.92 | 9.46 | 2.08 | 1.30 | 1.17 | 285.87 | 2.00 | 0.88 | 384.01 | 0.90 | 1.12 | 2.06 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -50.32 | -89.19 | -75.40 | -68.60 | -67.13 | -57.08 | -66.14 | -57.09 | -49.17 | -39.71 | -53.20 | -28.14 | 46.64 | |
Net Income Loss | -81.39 | -83.50 | -65.73 | -98.50 | -94.24 | -67.50 | -84.17 | -76.79 | -62.05 | -67.46 | -60.83 | -193.40 | -42.18 | |
Increase Decrease In Accounts Receivable | NA | -0.21 | 0.13 | -0.21 | -0.02 | 0.07 | -0.05 | 0.02 | -0.13 | -0.40 | 0.53 | 0.20 | -75.00 | |
Increase Decrease In Accounts Payable | 0.10 | -5.37 | -1.22 | 2.80 | 1.40 | 1.97 | 4.63 | -3.39 | -1.22 | 2.43 | -0.64 | -0.06 | -0.81 | |
Share Based Compensation | 27.19 | 19.27 | 21.84 | 23.41 | 21.52 | 13.82 | 13.72 | 15.15 | 13.46 | 10.22 | 12.42 | 16.15 | 9.67 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 10.53 | 59.68 | 71.36 | 51.28 | 75.31 | -146.94 | 27.19 | 43.39 | -112.38 | -292.75 | 20.79 | 26.07 | -233.62 | |
Payments To Acquire Property Plant And Equipment | 1.78 | 0.12 | 0.59 | 1.50 | 1.92 | 2.32 | 2.10 | 1.86 | 2.79 | 0.88 | 1.74 | 0.38 | 0.48 | |
Payments To Acquire Investments | 190.78 | 136.81 | 84.75 | 66.16 | 97.81 | 327.64 | 55.83 | 24.25 | 127.69 | 327.03 | 7.39 | 26.92 | 619.32 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 48.92 | 21.92 | 9.46 | 2.08 | 1.30 | 1.17 | 285.87 | 2.00 | 0.88 | 384.01 | 0.90 | 1.12 | 2.06 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 10.01 | -0.00 | 25.20 | 0.12 | 0.23 | 0.25 | 0.34 | 0.36 | 0.42 | 27.83 | 0.67 | 0.84 | 0.95 | |
Revenue From Contract With Customer Excluding Assessed Tax | 10.01 | -0.00 | 25.20 | 0.12 | 0.23 | 0.25 | 0.34 | 0.36 | 0.42 | 0.57 | 0.67 | 0.84 | 0.95 | |
Genentech Inc | 10.00 | NA | 25.10 | 0.10 | 0.20 | NA | 0.30 | 0.30 | 0.20 | NA | NA | NA | NA |